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In response to Cassel et al., we clearly agree that our
findings relate only to our employed blood alcohol
concentration (BAC) of 0.56 mg/ml. Different ethanol
concentrations may indeed induce different effects, and
research in animals such as that reported by Cassel et al.
(2005) suggest that higher doses may induce more dramatic
interactions. At the same time, it is unfeasible to examine
every possible combination of ethanol levels and 3,4-
methylenedioxymethamphetamine (MDMA) doses. Al-
though our design is inevitably a model, we believe that it
is appropriate for the estimation of the effects of recrea-
tional drug use by humans for the following reasons.
We employed an ethanol clamp that provides a contin-
uous steady-state BAC of approximately 0.6 mg/ml, which
is a radically different approach from the single oral
administration of alcohol as employed in the previous
studies mentioned by Cassel et al. Although our target BAC
reflects the peak achieved after 2–3 alcoholic drinks, due to
the continuous infusion of alcohol over 3 h to maintain this
BAC, the total amount of alcohol administered represents a
much larger intake of alcoholic drinks corresponding to
almost one bottle of wine, a relevant dose of ethanol which
is comparable to the amounts as cited by Cassel et al. in
relation to recreational drug use. As recreational alcohol
users are expected to spread their alcohol use over the
night, our design, thus, represents continuous moderate use
of alcohol. A single high dose of oral alcohol (based on
total drinks consumed during or around MDMA exposure),
on the other hand, will show a rapid increase and a steady
decline in BAC, resembling binge drinking. This will
induce larger peak effects compared to the effects of our
more steady infusion of alcohol. It is unknown whether
binge drinking or moderate continuous drinking is more
prevalent in MDMA users, and our study represents only
the latter pattern of alcohol use. Cassel et al. rightly point to
the lack of evidence regarding the real world drinking
behavior and achieved BAC by recreational drug users
combining MDMA and ethanol, and we welcome further
research regarding these uncertainties.
Next, Cassel et al. cites the study by Hernandez Lopez et
al. (2002) who achieved a higher BAC (employing a single
oral alcohol dose) and reported an increase in MDMA
concentration after ethanol coadministration (compared to
the MDMA only condition), an effect which we did not
find. This report indeed shows a significant increase in
MDMA peak levels (Cmax) but not for total MDMA
concentrations (AUC0—6 h). This is in line with our
expectations and suggestions regarding the difference
in ethanol administration route and resulting kinetics.
Hernandez-Lopez et al. (2002) also reported a decrease in
BAC after ethanol administration, which we did not address
in our report. A subsequent evaluation of our data indicated
that after MDMA coadministration, significantly more
ethanol was needed to maintain the same stable levels of
BAC compared to the ethanol only condition (effect of drug
condition on infusion rates over time: F(1,11)=8.537, p=
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0.014), in line with the report by Hernandez-Lopez et al.
(2002).
Cassel et al. also implies that our results differ from
previous human studies by Hernandez-Lopez et al. (2002)
and Kuypers et al. (2006), showing a dissociation between
subjective and objective measures of sedation and psycho-
motor function. However, we also report this dissociation.
Furthermore, although Hernandez-Lopez et al. (2002) did
note a lengthening of euphoria after coadministration of
ethanol and MDMA compared to MDMA alone, this effect
did not reach the level of statistical significance. Thus, our
results do not clearly seem to disagree with those of
previous studies, even if BACs were higher than in our
study, as in the case of Hernandez-Lopez et al. (2002).
In conclusion, we do not agree that our approach “most
probably misses the reality of what’s happening.” Rather,
we are of the opinion that our method represents social
drinking behavior that users would expect to be safe and
socially acceptable, and interactions with MDMA would,
hence, be very relevant, particularly for driving related
behavior. No research model can capture all possible real-
world behaviors of combined drinking and drug use, and
we agree that our model still is a crude estimation of real
world drinking behavior, which likely shows a more
fluctuating BAC and may affect cognitive function differ-
ently (Pohorecky and Brick 1988). However, administration
of a single high dose of ethanol may be an even cruder
abstraction of real world drinking behavior than relatively
constant levels over time. Irrespective of the above, we do
agree that higher BACs may yield different outcomes and
may provide important data regarding health risks of
recreational (binge) drug use. We, thus, welcome future
research regarding these issues, although tolerability and
ethical issues may hamper the use of much higher doses of
ethanol in humans.
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